Výsledky vyhledávání - "John J. Isitt"

Akademický článek

Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada

Autor: Hamza Alshannaq, John J Isitt, Richard F Pollock, Gregory J Norman, Greg Cogswell, Peter M Lynch, Stephane Roze

Publikováno v: Journal of Comparative Effectiveness Research, Vol 12, Iss 10 (2023)

Aim: Clinical trials and real-world data for Type 2 diabetes have shown that real-time continuous glucose monitoring (rt-CGM) lowers glycated hemoglobin (A1c) and reduces hypoglycemia relative to self-monitoring of blood glucose (SMBG). This analys

Externí odkaz: https://doaj.org/article/b67ef756c43e4c71baec05efe8a14e22

Zobrazit plný text záznamu

Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada

Autor: John J. Isitt, P. Lynch, Stéphane Roze, Jayne Smith-Palmer

Publikováno v: ClinicoEconomics and Outcomes Research: CEOR

Stephane Roze,1 John J Isitt,1 Jayne Smith-Palmer,2 Peter Lynch3 1Vyoo Agency, Paris, France; 2Ossian Health Economics and Communications, Basel, Switzerland; 3Dexcom, San Diego, CA, USACorrespondence: Jayne Smith-PalmerOssian Health Economics and Co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84bf748db7ab1c89c3c171861666e83a
https://doi.org/10.2147/ceor.s304395

Zobrazit plný text záznamu

Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System Versus Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Therapy in the UK

Autor: John J. Isitt, Stéphane Roze, Helen Sharland, Greg Cogswell, Hamza Alshannaq, Gregory J. Norman, Peter M. Lynch

Publikováno v: Diabetes therapy : research, treatment and education of diabetes and related disorders. 13(11-12)

Real-time continuous glucose monitoring (rt-CGM) involves the measurement and display of glucose concentrations, potentially improving glucose control among insulin-treated patients with type 2 diabetes (T2D). The present analysis aimed to conduct a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4739971880183981e67b8ab19b89226
https://pubmed.ncbi.nlm.nih.gov/36258158

Zobrazit plný text záznamu

Plný text ve formátu HTML

134-OR: Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System vs. Self-Monitoring of Blood Glucose in Type 2 Diabetes Patients on Insulin in Canada

Autor: JOHN J. ISITT, STEPHANE ROZE, GREGORY COGSWELL, PETER M. LYNCH

Publikováno v: Diabetes. 71

A health economic analysis was conducted to determine the cost-effectiveness of a real-time continuous glucose monitoring (rt-CGM) system versus self-monitoring of blood glucose (SMBG) in Type 2 diabetes (T2D) patients treated with insulin. The IQVIA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::654205a73619eaf29c29e0fb4c45dc72
https://doi.org/10.2337/db22-134-or

Zobrazit plný text záznamu

Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France

Autor: John J. Isitt, Pierre-Yves Benhamou, Gerald Zammit, Stéphane Roze, Brigitte Klinkenbijl, P. Lynch, Jayne Smith-Palmer

Publikováno v: Diabetes Therapy

Introduction The aim was to determine the long-term cost-effectiveness of the Dexcom G6 real-time continuous glucose monitoring (RT-CGM) system versus self-monitoring of blood glucose (SMBG) in adults with type 1 diabetes (T1D) in France. Methods The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0605f199e110d589c47406070247a431
https://pubmed.ncbi.nlm.nih.gov/33165838

Zobrazit plný text záznamu

174-OR: Budget Impact Analysis (BIA) Comparing Real-Time Continuous Glucose Monitoring (RT-CGM) with Self-Monitoring of Blood Glucose (SMBG) for all U.S. Medicaid Enrollees with Type 1 Diabetes

Autor: John J. Isitt, Michael E. Minshall, Claudia Graham, P. Lynch

Publikováno v: Diabetes. 69

A BIA was performed comparing clinical cost offsets for rt-CGM compared with SMBG for U.S. Medicaid enrollees with type 1 diabetes (T1D) over one year. Clinical effects for HbA1c reduction using rt-CGM (-1.0%) and SMBG (-0.4%) were taken from the DIA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::72ad789a8b1792e52804af0add3a4d8b
https://doi.org/10.2337/db20-174-or

Zobrazit plný text záznamu

67-LB: Clinical Cost Offset Analysis Comparing Real-Time CGM (RTCGM) with SMBG Based on the COMISAIR 3-Year Follow-Up Study

Autor: George Grunberger, Martin Prazny, Jan Šoupal, Michael E. Minshall, P. Lynch, Christopher G. Parkin, John J. Isitt

Publikováno v: Diabetes. 69

This clinical cost offset analysis compared rtCGM vs. SMBG in people with type 1 diabetes (T1D) applying results from a 3-year, nonrandomized, prospective, real-world clinical trial (COMISAIR). Clinical effects for HbA1c reduction using rtCGM vs. SMB

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fdcf3604d7811b1ea2c4e0c716d889ff
https://doi.org/10.2337/db20-67-lb

Zobrazit plný text záznamu

Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K

Autor: John J. Isitt, Stéphane Roze, Mehdi Javanbakht, P. Lynch, Jayne Smith-Palmer

Publikováno v: Diabetes care. 43(10)

OBJECTIVEA long-term health economic analysis was performed to establish the cost-effectiveness of real-time continuous glucose monitoring (RT-CGM) (Dexcom G6) versus self-monitoring of blood glucose (SMBG) alone in U.K.-based patients with type 1 di

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38ea9fe8a461e9b9e882e8008aa8963c
https://pubmed.ncbi.nlm.nih.gov/32647050

Zobrazit plný text záznamu

Autor: Alex Kouassi, John J. Isitt, Christian Heidbreder, Vijay R Nadipelli, Maurizio Fava

Publikováno v: Schizophrenia Research. 174:126-131

Background There is increased interest in the impact of new long-acting treatments on health-related quality of life (HRQoL) in patients with schizophrenia. The aim of this study was to evaluate the impact of treatment with subcutaneous injections of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c9260c1e9f072c1f81ca6cfefbc7271
https://doi.org/10.1016/j.schres.2016.03.020

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání